SaurabhChhabraMDMS
Oncology • Scottsdale, AZHematologic Oncology
Senior Associate Consultant, Mayo Clinic, Phoenix, AZ
Dr. Chhabra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
13400 E. Shea Blvd
Scottsdale, AZ 85259- Is this information wrong?
Summary
- Dr. Saurabh Chhabra is a hematologist/oncologist in Phoenix, AZ and is affiliated with Mayo Clinic. He received his medical degree from Delhi University College of Medical Sciences and has been in practice 20 years. He also speaks multiple languages, including Hindi. He specializes in hematologic oncology and is experienced in hematologic oncology, hematopoietic stem cell transplantation, bone marrow transplantation, CAR-T therapy, plasma cell myeloma, and plasma cell disorders. He has more than 150 publications and over 3500 citations.
Education & Training
Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 2011 - 2012
Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2008 - 2011- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2006 - 2008
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 2005 - 2006
Delhi University College of Medical SciencesClass of 2001
Certifications & Licensure
SC State Medical License 2012 - 2025
WI State Medical License 2016 - 2025
AZ State Medical License 2022 - 2025
CA State Medical License 2011 - 2024
NJ State Medical License 2008 - 2011- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
- Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) Start of enrollment: 2014 Aug 01
- Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Start of enrollment: 2015 Jun 01
Publications & Presentations
PubMed
- Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogen...Chhabra, S., Jerkins, J., Monahan, K., Szabo, A., Shah, N., Abedin, S., Runaas, L., Fenske, T., Pasquini, M., Shaw, B., Drobyski, W., Saber, W., D'Souza, A., Dhakal, B...> ;Bone Marrow Transplantation. 2024 Mar 1
- Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.Abid, M. B., Hemant S Murthy, Mei-Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly, Ankit Kansagra, Fotios V Michelis, Taiga Nishihori, Mrinal Pat...> ;Blood Advances. 2023 Nov 28
- 4 citationsMinimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial.Costa, L., Chhabra, S., Medvedova, E., Dholaria, B., Schmidt, T., Godby, K., Silbermann, R., Dhakal, B., Bal, S., Giri, S., D'Souza, A., Hall, A., Hardwick, P., Omel, ...> ;The Lancet. Haematology. 2023 Nov 1
- Join now to see all
Journal Articles
- Second Primary Malignancy After Multiple Myeloma‐Population Trends and Cause‐Specific MortalityParameswaran Hari, Luciano J Costa, Saurabh Chhabra, Kelly N Godby, British Journal of Haematology
Abstracts/Posters
- Population-Level Trends in Early Mortality and Overall Survival of Patients with Multiple Myeloma. Are We Facing Stagnation?Saurabh Chhabra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...Saurabh Chhabra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizu...Saurabh Chhabra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Adjuvant Doxycycline to Enhance Anti-Amyloid Effects: Results from the DUAL (Doxycycline to Upgrade response in AL amyloidosis) Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Phase I/II Trial of Bendamustine, Ixazomib and Dexamethasone (BID) in Patients (pts.) with Relapsed/Refractory Multiple Myeloma (RRMM)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Weighing Conditioning Regimens for Patients with CML Undergoing TransplantJanuary 1st, 2019
Professional Memberships
- American Society of HematologyMember
- American Society of Blood and Marrow TransplantationMember
Other Languages
- Hindi, Urdu
Hospital Affiliations
Mayo Clinic HospitalPhoenix, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
